Antex Pharma Private Limited, a active private limited company, was established on 06 March 2009 in Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24100DL2009PTC188276. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹7.00 M and a paid-up capital of ₹7.00 M.
It upholds a compliant status. Its leadership includes Rajesh Kumar Hariharprasad Tiwari (Director), Amardeep Bansal (Director). Past directors included Naveen Kumar, Ashok Swan, Rajesh Kumar Hariharprasad Tiwari. It holds ₹13.50 Cr open charges and ₹13.20 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 423, Main Bawana Road Shahbad Daulatpur, Delhi, Delhi, 110042.
U24100DL2009PTC188276
188276
06 March 2009
₹7.00 M
₹7.00 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Antex Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajesh Kumar Hariharprasad Tiwari | Director | 12 Dec 2019 | Current |
| Amardeep Bansal | Director | 06 Mar 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 11 May 2018 | Past |
| Pramod Abcsdd | Additional Director | 21 Jul 2011 | Past |
| Pramod Abcsdd | Additional Director | 09 May 2025 | Past |
| Pramod Abcsdd | Additional Director | 12 Dec 2019 | Past |
| Pramod Abcsdd | Director | 19 Apr 2010 | Past |
| Pramod Abcsdd | Director | 11 May 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Antex Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 19.08% decrease. The company also saw a substantial improvement in profitability, with a 42.37% increase in profit. The company's net worth Soared by an impressive increase of 34.73%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Antex Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹135,000,000.00
₹131,992,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Oct 2025 | Hdfc Bank Limited | ₹8.00 Cr | Open |
| 18 Oct 2023 | Yes Bank Limited | ₹5.00 Cr | Open |
| 24 Oct 2020 | Hdfc Bank Limited | ₹5.00 M | Open |
| 25 Nov 2024 | Uco Bank | ₹4.95 Cr | Satisfied |
| 02 Jul 2015 | Hdfc Bank Limited | ₹6.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Antex Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Antex Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Antex Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 25 Nov 2024 via Charge ID 101011816 with Uco Bank was fully satisfied on 30 Oct 2025. was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 80.00 M with Charge ID 101179563 was registered on 25 Oct 2025. was documented.
Progress on A charge with Uco Bank amounted to Rs. 49.50 M with Charge ID 101011816 was registered on 25 Nov 2024. was documented.
The activity Antex Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Antex Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
The activity A charge with Yes Bank Limited amounted to Rs. 50.00 M with Charge ID 100803158 was registered on 18 Oct 2023. was completed.
The CIN of Antex Pharma Private Limited is U24100DL2009PTC188276.
Antex Pharma Private Limited is headquartered at 423, Main Bawana Road Shahbad Daulatpur, Delhi, Delhi, 110042.
Antex Pharma Private Limited was incorporated on 06 March 2009.
The current directors of Antex Pharma Private Limited are
The primary industry of Antex Pharma Private Limited is Trade.
Antex Pharma Private Limited is unlisted.
The authorized capital of Antex Pharma Private Limited is ₹7.00 M, and the paid-up capital is ₹7.00 M.
The compliance status of Antex Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX